Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from BIOBADASER
28/06/2024
Otero-Varela L, Alvaro-Gracia J, Calvo J, Campos C, Garcia Dorta A, Sánchez-Alonso F, Castrejon I
ACR 2023
Otero-Varela L, Alvaro-Gracias J, Calvo J, Campos C, Garcia Dorta A, Sánchez-Alonso F, Castrejon I. Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from BIOBADASER [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/glucocorticoid-use-in-rheumatoid-arthritis-patients-initiating-biological-or-targeted-synthetic-disease-modifying-anti-rheumatic-drugs-b-tsdmards-in-real-life-data-from-biobadaser/
https://acrabstracts.org/abstract/glucocorticoid-use-in-rheumatoid-arthritis-patients-initiating-biological-or-targeted-synthetic-disease-modifying-anti-rheumatic-drugs-b-tsdmards-in-real-life-data-from-biobadaser/